Using the established QDs-based immunofluorescence histochemistry (QDs-IHC) and QDs-based double immunofluorescent labelling methods, we focused on the expression of fibroblastic Cav-1 and LC3B in GC, followed by analysis of the correlation with GC prognosis. This evidence concerns the gene MAP1LC3B and gastric cancer.